The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing Charles River's immunology expertise to refine study paramet ...
Systemic lupus erythematosus (SLE) is an autoimmune disease that sometimes involves the central nervous system in a condition known as neuropsychiatric SLE (NPSLE). Research in mice has shown that ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...
July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...
Selena Gomez has been in the spotlight thanks to her Golden Globe nomination for Emilia Pérez and her engagement to musician ...
Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...
In this article (Part II of II), the focus is on scarring alopecias (dissecting folliculitis, folliculitis decalvans, lichen planopilaris, lupus erythematosus) in regard to pathogenesis ...
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...
A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results